Detalhe da pesquisa
1.
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.
Invest New Drugs
; 32(1): 113-22, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23568716
2.
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
HPB (Oxford)
; 15(2): 106-15, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297721
3.
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Cancer Chemother Pharmacol
; 87(4): 525-532, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423090
4.
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.
Cancer Chemother Pharmacol
; 84(6): 1201-1208, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522242
5.
A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine.
Cancer Chemother Pharmacol
; 75(3): 537-46, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25567350
6.
Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.
Oncology (Williston Park)
; 17(9 Suppl 8): 13-5, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-14569841
7.
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
J Clin Oncol
; 29(34): 4555-60, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22025151
8.
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
J Clin Oncol
; 25(30): 4793-9, 2007 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947727